Geninnov

Healthcare

February 9, 2026

Shedding the Skin of Scandal: The Unbridled Paradox of Chinese Drug Discovery

Massive reforms, global deals and proven FDA approvals suggest Chinese clinical data deserves far more credit than skeptical markets allow.

January 29, 2026

China’s Pharma Foundry

The untold story of how contract labs became a pharmaceutical superpower. China didn't just join the drug discovery race; it rewrote the rules.

Archisha Mukherjee

January 22, 2026

The Accelerationist State: China’s Biopharma Industrialization

China’s biopharma surge is policy-made: statutory clocks, silent approvals, and scaled expertise—creating a pipeline too fast to ignore

November 2, 2025

Takeda Blinked. Markets Didn’t. China’s Quiet Big-Pharma Break-In

Chinese pharma's breakthroughs are upending many important drivers and notions of the whole global healthcare industry

AI’s Uneven Progress in Healthcare Subsegments

We evaluate five segments for the impact of AI, and feel that instrumentations may see the earliest winners

Articles on innovation

Our Latest Articles

Hidden in Plain Sight: the AI within Xiaomi

Many lessons from Xiaomi’s frontier-class model buiit from a standing start in a single year

Two Sides of the Coin

A season of games. Some played well, some badly, all of them in plain sight.

Is DRAM at a Permanently Higher Plateau?

A treatise on memory industry for what it is and has become, rather than on everything else supposedly driving it